Literature DB >> 28133816

Typical and atypical pathology in primary progressive aphasia variants.

Edoardo G Spinelli1,2, Maria Luisa Mandelli1, Zachary A Miller1, Miguel A Santos-Santos1, Stephen M Wilson1,3, Federica Agosta2, Lea T Grinberg1, Eric J Huang1, John Q Trojanowski4, Marita Meyer1, Maya L Henry5, Giancarlo Comi2, Gil Rabinovici1, Howard J Rosen1, Massimo Filippi2, Bruce L Miller1, William W Seeley1, Maria Luisa Gorno-Tempini1.   

Abstract

OBJECTIVE: To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by current diagnostic classification.
METHODS: Extensive clinical, cognitive, neuroimaging, and neuropathological data were collected from 69 patients with sporadic PPA, divided into 29 semantic (svPPA), 25 nonfluent (nfvPPA), 11 logopenic (lvPPA), and 4 mixed PPA. Patterns of gray matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of pathological diagnosis using support vector machine (SVM) algorithms.
RESULTS: A clinical diagnosis of PPA was associated with frontotemporal lobar degeneration (FTLD) with transactive response DNA-binding protein (TDP) inclusions in 40.5%, FTLD-tau in 40.5%, and Alzheimer disease (AD) pathology in 19% of cases. Each variant was associated with 1 typical pathology; 24 of 29 (83%) svPPA showed FTLD-TDP type C, 22 of 25 (88%) nfvPPA showed FTLD-tau, and all 11 lvPPA had AD. Within FTLD-tau, 4R-tau pathology was commonly associated with nfvPPA, whereas Pick disease was observed in a minority of subjects across all variants except for lvPPA. Compared with pathologically typical cases, svPPA-tau showed significant extrapyramidal signs, greater executive impairment, and severe striatal and frontal GM and WM atrophy. nfvPPA-TDP patients lacked general motor symptoms or significant WM atrophy. Combining GM and WM volumes, SVM analysis showed 92.7% accuracy to distinguish FTLD-tau and FTLD-TDP pathologies across variants.
INTERPRETATION: Each PPA clinical variant is associated with a typical and most frequent cognitive, neuroimaging, and neuropathological profile. Specific clinical and early anatomical features may suggest rare and atypical pathological diagnosis in vivo. Ann Neurol 2017;81:430-443.
© 2017 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28133816      PMCID: PMC5421819          DOI: 10.1002/ana.24885

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  49 in total

1.  Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer's disease presenting as logopenic progressive aphasia.

Authors:  Keith A Josephs; Dennis W Dickson; Melissa E Murray; Matthew L Senjem; Joseph E Parisi; Ronald C Petersen; Clifford R Jack; Jennifer L Whitwell
Journal:  Brain Lang       Date:  2013-03-28       Impact factor: 2.381

2.  Prion-like properties of pathological TDP-43 aggregates from diseased brains.

Authors:  Takashi Nonaka; Masami Masuda-Suzukake; Tetsuaki Arai; Yoko Hasegawa; Hiroyasu Akatsu; Tomokazu Obi; Mari Yoshida; Shigeo Murayama; David M A Mann; Haruhiko Akiyama; Masato Hasegawa
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

Review 3.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

4.  Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy.

Authors:  Andrea Cherubini; Maurizio Morelli; Rita Nisticó; Maria Salsone; Gennarina Arabia; Roberta Vasta; Antonio Augimeri; Maria Eugenia Caligiuri; Aldo Quattrone
Journal:  Mov Disord       Date:  2013-12-03       Impact factor: 10.338

5.  Automated MRI-based classification of primary progressive aphasia variants.

Authors:  Stephen M Wilson; Jennifer M Ogar; Victor Laluz; Matthew Growdon; Jung Jang; Shenly Glenn; Bruce L Miller; Michael W Weiner; Maria Luisa Gorno-Tempini
Journal:  Neuroimage       Date:  2009-06-06       Impact factor: 6.556

6.  Classification and pathology of primary progressive aphasia.

Authors:  Jennifer M Harris; Claire Gall; Jennifer C Thompson; Anna M T Richardson; David Neary; Daniel du Plessis; Piyali Pal; David M A Mann; Julie S Snowden; Matthew Jones
Journal:  Neurology       Date:  2013-10-18       Impact factor: 9.910

7.  Clinical and pathological characterization of progressive aphasia.

Authors:  Jonathan A Knibb; John H Xuereb; Karalyn Patterson; John R Hodges
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

8.  Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia.

Authors:  Yu Zhang; Norbert Schuff; Christopher Ching; Duygu Tosun; Wang Zhan; Marzieh Nezamzadeh; Howard J Rosen; Joel H Kramer; Maria Luisa Gorno-Tempini; Bruce L Miller; Michael W Weiner
Journal:  Int J Alzheimers Dis       Date:  2011-06-27

9.  Trans-synaptic spread of tau pathology in vivo.

Authors:  Li Liu; Valerie Drouet; Jessica W Wu; Menno P Witter; Scott A Small; Catherine Clelland; Karen Duff
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

10.  Temporal Variant Frontotemporal Dementia is Associated with Globular Glial Tauopathy.

Authors:  Camilla N Clark; Tammaryn Lashley; Colin J Mahoney; Jason D Warren; Tamas Revesz; Jonathan D Rohrer
Journal:  Cogn Behav Neurol       Date:  2015-06       Impact factor: 1.600

View more
  118 in total

1.  Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.

Authors:  Bob Olsson; Erik Portelius; Nicholas C Cullen; Åsa Sandelius; Henrik Zetterberg; Ulf Andreasson; Kina Höglund; David J Irwin; Murray Grossman; Daniel Weintraub; Alice Chen-Plotkin; David Wolk; Leo McCluskey; Lauren Elman; Leslie M Shaw; Jon B Toledo; Jennifer McBride; Pilar Hernandez-Con; Virginia M-Y Lee; John Q Trojanowski; Kaj Blennow
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

2.  Treatment for Word Retrieval in Semantic and Logopenic Variants of Primary Progressive Aphasia: Immediate and Long-Term Outcomes.

Authors:  Maya L Henry; H Isabel Hubbard; Stephanie M Grasso; Heather R Dial; Pélagie M Beeson; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  J Speech Lang Hear Res       Date:  2019-08-07       Impact factor: 2.297

3.  "Looks familiar, but I do not know who she is": The role of the anterior right temporal lobe in famous face recognition.

Authors:  Valentina Borghesani; Jared Narvid; Giovanni Battistella; Wendy Shwe; Christa Watson; Richard J Binney; Virginia Sturm; Zachary Miller; Maria Luisa Mandelli; Bruce Miller; Maria Luisa Gorno-Tempini
Journal:  Cortex       Date:  2019-01-23       Impact factor: 4.027

Review 4.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Authors:  Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger
Journal:  Lancet Neurol       Date:  2017-06-13       Impact factor: 44.182

Review 5.  Primary progressive aphasia: a model for neurodegenerative disease.

Authors:  Boon Lead Tee; Maria Luisa Gorno-Tempini
Journal:  Curr Opin Neurol       Date:  2019-04       Impact factor: 5.710

6.  Clinical Features of Late-onset Semantic Dementia.

Authors:  Mario F Mendez; Diana Chavez; Randy E Desarzant; Oleg Yerstein
Journal:  Cogn Behav Neurol       Date:  2020-06       Impact factor: 1.600

7.  Speech production differences in English and Italian speakers with nonfluent variant PPA.

Authors:  Elisa Canu; Federica Agosta; Giovanni Battistella; Edoardo G Spinelli; Jessica DeLeon; Ariane E Welch; Maria Luisa Mandelli; H Isabel Hubbard; Andrea Moro; Giuseppe Magnani; Stefano F Cappa; Bruce L Miller; Massimo Filippi; Maria Luisa Gorno-Tempini
Journal:  Neurology       Date:  2020-01-10       Impact factor: 9.910

Review 8.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

Review 9.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 10.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.